174 related articles for article (PubMed ID: 21951151)
1. Analysis of 256 cases of basal cell carcinoma after either one-step or two-step surgery in a Japanese institution.
Goto M; Kai Y; Arakawa S; Oishi M; Ishikawa K; Anzai S; Hatano Y; Okamoto O; Katagiri K; Fujiwara S; Shimizu F; Kato A; Shibuya H; Eshima N; Terashi H
J Dermatol; 2012 Jan; 39(1):68-71. PubMed ID: 21951151
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis after surgical excision of basal cell carcinoma: a single institutional study in Japan.
Takenouchi T; Takatsuka S
J Dermatol; 2013 Sep; 40(9):696-9. PubMed ID: 23803167
[TBL] [Abstract][Full Text] [Related]
3. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
4. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
[TBL] [Abstract][Full Text] [Related]
5. Is it really necessary to make wide excisions for basal cell carcinoma treatment?
Unlü RE; Altun S; Kerem M; Koç MN
J Craniofac Surg; 2009 Nov; 20(6):1989-91. PubMed ID: 19881375
[TBL] [Abstract][Full Text] [Related]
6. [The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].
Breuninger H; Schippert W; Black B; Rassner G
Hautarzt; 1989 Nov; 40(11):693-700. PubMed ID: 2606668
[TBL] [Abstract][Full Text] [Related]
7. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
8. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma in Turkey.
Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
J Dermatol; 2006 Feb; 33(2):91-5. PubMed ID: 16556274
[TBL] [Abstract][Full Text] [Related]
10. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
11. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
12. [Basal cell carcinoma of the nose].
Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
[TBL] [Abstract][Full Text] [Related]
13. [Two-stage excision of extensive cutaneous carcinoma of the face. A retrospective study of 80 patients].
Arfi C; Bureau B; Beauvillain C; Nguyen JM; Stalder JF; Litoux P
Ann Dermatol Venereol; 1995; 122(11-12):764-8. PubMed ID: 8729820
[TBL] [Abstract][Full Text] [Related]
14. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
[TBL] [Abstract][Full Text] [Related]
15. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
16. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
17. [Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy].
Tarallo M; Cigna E; Fino P; Sorvillo V; Scuderi N
Ann Ital Chir; 2011; 82(5):389-94. PubMed ID: 21988047
[TBL] [Abstract][Full Text] [Related]
18. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
19. [The evaluation of tumor histopathology, location, characteristic, size and thickness of nonmelanoma skin cancers of the head and neck].
Eskiizmir G; Ozgür E; Temiz P; Gençoğlan G; Ermertcan AT
Kulak Burun Bogaz Ihtis Derg; 2012; 22(2):91-8. PubMed ID: 22548266
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]